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Abstract
A structural model of the adduct between human cytochrome c and the human anti-apoptotic protein Bcl-xL, which defines
the protein-protein interaction surface, was obtained from solution NMR chemical shift perturbation data. The atomic level
information reveals key intermolecular contacts identifying new potentially druggable areas on cytochrome c and Bcl-xL.
Involvement of residues on cytochrome c other than those in its complexes with electron transfer partners is apparent. Key
differences in the contact area also exist between the Bcl-xL adduct with the Bak peptide and that with cytochrome c. The
present model provides insights to the mechanism by which cytochrome c translocated to cytosol can be intercepted, so
that the apoptosome is not assembled.
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Introduction
Cytochrome c is a small soluble heme protein loosely associated
with the inner membrane of the mitochondrion, where it acts as an
electron carrier between the two terminal complexes of the
respiration chain, cytochrome bc1 and cytochrome c oxidase [1],
[2]. The release into the cytosol of cytochrome c is a critical early
event in mitochondrially mediated apoptotic cell death [3]. Upon
extrusion into the cytosol, cytochrome c forms the apoptosome
with Apaf-1 and pro-caspase-9, initiating the caspase cascade of
reactions that leads to apoptosis [4]. In absence of cytochrome c,
cytosolic Apaf-1 is unable to bind pro-caspase-9 and caspase
activation does not occur. Despite its celebrity, the mechanism of
cytochrome c release remains largely elusive. It has been proposed
to occur in two steps: the upstream event of cytochrome c
dissociation from the inner membrane that renders it available for
the subsequent release into the cytosol upon permeabilization of
the outer mitochondrial by oligomeric pro-apoptotic members of
the Bcl-2 family of proteins [5]. Oxidative damage of cardiolipin, a
phospholipid that constitutes about 20% of the total lipid
composition of the inner membrane, may cause the cytochrome
c detachment from the inner membrane [5], [6]. The external
membrane permeabilization step is both positively and negatively
regulated by members of the Bcl-2 family of proteins [7], [8], [9],
through their cytosol-to-external mitochondrial membrane redis-
tribution by means of activated processes [10], [8]. The BH3-only
proteins initiate apoptosis through binding to pro-apoptotic Bax or
Bak and recruiting them to the membrane, where they form large
complexes that generate membrane spanning pores, hence making
the membrane permeable [11]. Anti-apoptotic members of the
Bcl-2 family, such as Bcl-xL, are structurally similar to Bax but
inhibit the membrane permeabilization process, do not oligomer-
ize and do not form pores [12]. They might inhibit apoptosis by
acting as if they were a dominant-negative version of Bax by
competing with it for binding to the outer membrane [12].
Pro-survival proteins like Bcl-xL do prevent cytochrome c
release into the cytosol: a number of diverse protein-protein
interactions have been proposed to be at the basis of such a
process. There have been reports that Bcl-xL can block the
formation of the apoptosome associating itself with Apaf-1 and
caspase-9 to produce an anti-apoptotic ternary complex [13], [14].
On the other hand cytochrome c was found to interact specifically
with Bcl-xL in vitro with an affinity that closely matches the
reported affinities of BH3 peptides/domains for Bcl-xL [15]. The
bimolecular binding rate of Bcl-xL to cytochrome c is also within
the range set by dimerization of Bcl-2 family proteins, and by
BH3–Bcl-2 protein interactions [15].
In the present study, we report an NMR-derived model
structure of human Bcl-xL in complex with human cytochrome
c, in its iron(II) form that should represent the relevant redox state
for heme iron in the reducing environment of the cytosol. Based
on this model, insights into the role of specific amino acids on both
partner molecules for the establishment of key interactions are
obtained that offer structural basis for the rational design of
inhibitors.
Results and Discussion
Chemical shift changes provide a highly sensitive tool for
identifying the residues that play a role in interprotein interactions.
NMR chemical shift perturbations of backbone amides in Bcl-xL
and reduced cytochrome c reveal that the two proteins form
detectable amounts of an adduct. The observed chemical shift
variations are small (Fig. S1 and Fig. S2), but increase in a
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1saturable manner upon titration (Fig. S3). The interaction between
cytochrome c and Bcl-xL has been reported to be strongly
dependent on ionic strength [15]: in 50 mM phosphate buffer, the
Kd of 1.2 10
27 M at 80 mM NaCl increases by nearly 12-fold in
the presence of 600 mM NaCl. The relatively high concentrations
required for the NMR experiments of these two heavily charged
proteins (total charge: 214 for Bcl-xL and +9 for cytochrome c)
contribute to the increase of the overall ionic strength of the
solution, setting us farther from the optimal conditions for the
complex formation. Consistently, the Kd values estimated from
our chemical shift data (Fig. S3), although measured at 50 mM
phosphate buffer and 150 mM NaCl, are of the order of 1 mM.
The maximum chemical shift variation here observed for
cytochrome c resonances is about J of the maximum value
reported for cytochrome c in its interaction with cytochrome b5,
where a Kd of 2 mM was estimated [16]. For the same system,
increasing salt concentration was reported to lead to the uniform
decrease of the observed chemical shift perturbation values for all
affected residues of both proteins [17]. The low affinity of the
complex combined with the intrinsic low solubility of Bcl-xL
prevented us from achieving protein concentrations in solution
higher than 500 mM for the anti-apoptotic protein, that would
have provided larger amount of the bound state and therefore
larger chemical shift perturbations.
An overall increase in
15N transverse relaxation rate values, R2,
is observed upon titration of Bcl-xL with cytochrome c, which is
consistent with an increase in the overall tumbling correlation time
upon complex formation [18]. An accurate measure of
15NR 2 in
the complex, however, was hampered by the low stability of Bcl-
xL, caused by local sample heating associated to this type of
measurements.
Residues whose chemical shift values are affected by the
presence of the partner molecule, when mapped on the proteins’
surface, were confined to well defined areas, suggesting the
formation of a specific, albeit transient, complex. The restraints
derived from the NMR experiments were used as input data for
docking calculations for the human cytochrome c2Bcl-xL system
with the program HADDOCK [19] and unequivocally define the
interface on both proteins.
The obtained ensemble of structural models is constituted by a
well defined cluster (Table S1) of 128 conformers with backbone
RMSD of 0.860.5 A ˚ from the overall lowest energy structure.
The dominant contribution to the total interaction energy comes
from the electrostatic term. This is consistent with the experimen-
tal finding that the interaction affinity is reduced by an increase in
ionic strength [15].
A buried surface area of the order of about 2,000 A ˚ 2 was
identified, which contrasts with the short-lived nature of the
complex, for which values ,1,200 A ˚ 2 would be expected. A
similar situation has been already reported for the cytochrome
c2CuA adduct and explained in terms of a biased picture resulting
from the docking procedure [20]; dense networks of intermolec-
ular contacts are provided in the same structural model as if they
could be contemporarily present, whereas, reasonably, only a
fraction of them is actually formed on average. This situation
results from the fact that all the active residues in HADDOCK
calculations are treated equivalently, without any attempt to score
them on the basis of relative importance to the affinity of the
complex. Consistently with this view, the relatively large restraint
violation energy hints that none of the calculated structures
satisfies all the experimental constraints. Observed chemical shift
perturbations in solution reflect the average effect of various
interconverting adducts with slightly different binding contacts, as
summarized in Table 1. Considering all the identified contacts (as
shown in Fig. 1), they define a large and flat contact area between
the two partner proteins, that may constitute a valuable guide for
Table 1. Intermolecular contacts statistics calculated over the 128 model structures of cluster 1 obtained by HADDOCK; all
contacts with repetition frequency .30 are listed.
Interacting residues Interaction type Frequency
Bcl-xL cytochrome c
Glu96 (Oe1, Oe2) Lys53 (Hf1,Hf2,Hf3) H-bond 141
Arg100 (Hg12, Hg21, Hg22) Gly41 (CO) H-bond 64
Tyr101 (Hg) Ala43 (CO) H-bond 31
Tyr101 (Ce1,Cc,Cf) Ala43 (Ca,Cb) non-bonded contact 195
Asp133 (Od2) Lys25 (Hf1,Hf2,Hf3) H-bond 87
Asp133 (Od1, Od2) His26 (HN) H-bond 36
Asn136 (Hd21, Hd22) His26 (CO) H-bond 44
Asn136 (Cb,Cc) Tyr46 (Cd1) non-bonded contact 82
Trp137 (Cb) Ser47 (Cb) non-bonded contact 43
Gly138 (CO) Gly45 (CO) non-bonded contact 54
Gly138 (Ca) Tyr46 (CO,Ca) non-bonded contact 128
Thr190 (Cc2) Lys79 (Ce) non-bonded contact 42
Phe191 (Ce1) Ser47 (Cb) non-bonded contact 32
Leu194 (CO) Ala50 (NH) H-bond 47
Leu194 Backbone (CO) Ala50 (Cb) non-bonded contact 32
Tyr195 (OH) Lys53 (Hf1,Hf2,Hf3) H-bond 48
Tyr 195 (Ca,Cd1) Ala50 (Cb) non-bonded contact 72
Ser203 (Hc) Asn54 (Od1) H-bond 45
doi:10.1371/journal.pone.0018329.t001
Bcl-xL - Cytochrome C Complex
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interaction.
Bcl-xL surface contacts with cytochrome c
The structure of Bcl-xL consists of seven helices (according to
the PDB analysis of 1LXL) of variable length and a long flexible
loop, spanning residues 45 to 84 [21], [22]. The C-terminal part
contains a hydrophobic tail proposed to constitute the anchoring
point in the membrane bound form. At the base of this short tail
the protein fold forms a large and flat surface (Fig. 2), that in the
membrane-bound form should be oriented towards the mitochon-
drion. Residues in contact with cytochrome c are all located in this
area. In particular: Glu96 and Tyr101 are on helix-3; Glu129 and
Arg139 are the penultimate and the first residue, respectively, of
helix-4 and helix-5, which are antiparallel to each other and
perpendicular to helix-3; residues 133–138 are on the loop
connecting helix-4 to helix-5; Trp181, Glu184 and Asn185 are on
helix-7 and Thr190, Glu193 and Leu194 on helix-8, two short
helices roughly parallel to helix-3; finally, the last two residues
forming contacts are Tyr195, immediately after helix-7 and
Ser203 at the base of the C-term tail.
Their spatial location with respect to the anchoring tail suggests
that cytochrome c is captured by the protein just at its entrance
into the cytosolic space.
Arg139, whose mutation into Glu has been reported to inhibit
the anti-apoptotic activity of Bcl-xL [22], is involved in the
interaction with cytochrome c and also with the Bak peptide;
otherwise the contact surfaces residues of Bcl-xL with the two
counterparts do not coincide. Complexation of Bcl-xL with the
pro-apoptotic Bak peptide(s) has been reported to occur through
an extended interaction with the hydrophobic cleft of Bcl-xL
defined by helices 3 and 4; in addition a few charged side chains of
opposite signs on the two partners are facing each other [22].
The non-coincidence of the contact surface areas in the two
adducts may provide hints for differently targeting the pro-
apoptotic and the anti-apoptotic protein-protein interactions.
Cytochrome c surface contacts with Bcl-xL and
comparison with cytochrome c electron transfer
complexes
The cytochrome c fold presents five a-helices and a short
antiparallel b-strand on one face and two extended loops on the
other (Fig. 3) [23], [24], [25], [2]. The two loops sandwich on the
heme providing the two axial ligands of the heme iron i.e. His18
and Met80. The porphyrin ring is partially solvent exposed on the
side defined by the two loops. Residues on cytochrome c involved
in contacts with Bcl-xL are located on the two loops, the helix-3
(also called 50’s helix) and on the b-strand (Fig. 3A). Although
input active residues in HADDOCK calculations are treated
equivalently without any attempt to score them on the basis of
relative chemical shit perturbation, the interaction areas resulting
from the calculations are centered on the most affected residues
i.e., His26 and Gly41. Interestingly, the only known pro-apoptotic
mutant of cytochrome is G41S [26], a variant bearing a mutation
on a residue of the b-strand found to form an H-bond with Arg100
of Bcl-xL in 64 out of 128 structures of our ensemble. The
chemical shift of the amide of Gly41 is the second most affected
signal of cytochrome c. However, residues proposed to play a role
in the interaction with Apaf-1 [27], [28], with the exception of
Lys25, do not match those identified here as contacts with Bcl-xL.
Lys25 side chain forms an H-bond with Asp133 of Bcl-xL in 87 out
of 128 conformers of our cluster 1. Consistently, the two residues
adjacent to it, Gly24 and His26, do experience chemical shift
perturbations upon binding to Bcl-xL, with His26 being the most
affected amide on cytochrome c. Unfortunately, the low resolution
of the recent structure of the apoptosome obtained by cryo-EM
prevented any inference regarding intermolecular contacts involv-
ing cytochrome c [29], [30].
The observed distribution of contact residues on cytochrome c
differs from that in its electron transfer complexes (Fig. 3B–D), as
detailed below.
Figure 1. Cytochrome c2Bcl-xL adduct. Residues on cytochrome c
(gray and cyan) and Bcl-xL (pink and violet) involved in intermolecular
contacts in our structural model. They have been mapped on the
lowest energy structure of our cluster of 128 conformers.
doi:10.1371/journal.pone.0018329.g001
Figure 2. Bcl-xL interaction areas. Ribbon representation of the
structure of Bcl-xL: the putative transmembrane hydrophobic tail points
towards the bottom part of the picture. Residues involved in contacts
with cytochrome c are represented as blue spheres. The Bak peptide is
shown in magenta and its interaction area has only a few contact points
with that defined for cytochrome c.
doi:10.1371/journal.pone.0018329.g002
Bcl-xL - Cytochrome C Complex
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counterparts in the respiratory chain requires rapid adduct
formation and rapid product dissociation as well as the
achievement of proper orientation of the partner proteins in the
transient adduct to optimize the electron transfer rate. Such
requirements are reflected in the high Kd values, namely in the
mM-mM range [31], [32], and in the nature of key interactions
involving surface residues surrounding the heme crevice of
cytochrome c. The optimal interfacial arrangement is tuned by
hydrophobic interactions among short range contacts. The
transient nature of the complex is assured by the possibility to
switch on and off the potential electrostatic interactions among
residues of different sign surrounding the contact central region on
the two proteins. Long-range recognition of the partners is driven
by non-specific electrostatic interactions that rely on the presence
of large patches of opposite charge on the two protein surfaces.
No structural information is available for the eukaryotic
cytochrome c - cytochrome c oxidase complex. Given the high
homology in the involved protein domains, the bacterial complex
has been proposed in the literature as a suitable model system to
achieve functional information that can be extrapolated to its
eukaryotic counterpart [20], in spite of the much higher structural
complexity of the cytochrome c oxidase of the latter. Even if the
per residue contacts may be different in the eukaryotic complex,
the overall interaction areas are expected to be the same. In the
various conformers of the structural model of the adduct between
cytochrome c552 and the CuA subunit of cytochrome c oxidase
from Paracoccus denitrificans (Fig. 3B) [20] common hydrophobic
patches (involving residues Ala16, Val26, Ala79, Phe80, and Ala81
on the cytochrome c552) are found, while different networks of
electrostatic intermolecular interactions are established within
negatively charged Asp and Glu contiguous to the central
hydrophobic surface area on cytochrome c oxidase and the
positively charged Lys residues, namely Lys13, Lys15, Lys19,
Lys70, Lys74 and Lys77, surrounding the heme crevice on the
cytochrome c552.
In the crystal structure of the complex between cytochrome c
and cytochrome bc1 from Saccharomyces cerevisiae (Fig. 3C) [33] the
interaction with the subunit cytochrome c1 of the enzyme is mainly
mediated by non polar contacts involving residues Thr12, Arg13,
Val28 and Ala81 on cytochrome c. Weak, polar interactions
involving Lys79 and Lys86 are present, while additional
electrostatic interactions (i.e. cytochrome c Lys87) have been
proposed to modulate intermediate states and the unbinding step.
The crystal structure of the complex between S. cerevisiae
cytochrome c and its redox soluble partner cytochrome c
peroxidase reveals that hydrophobic interactions are the predom-
inant forces holding the complex together (Fig. 3D) [34]. On the
side of cytochrome c, they involve residues Leu9, Arg13, Gln16,
Cys17, Ala81, Phe82, Gly83 and Lys86. The side chains of Asn70,
Lys73 and Lys87 are potentially involved in hydrogen bonds and/
or salt bridges.
The key residues for the interaction of cytochrome c with its
various redox partners do not coincide but identify similar contact
Figure 3. Hydrophobic and electrostatic contacts in cytochrome c complexes. Residues involved in hydrophobic (blue spheres) and in
electrostatic/H-bond (red spheres) interactions are shown for: (A) human cytochrome c and Bcl-xL, (B) cytochrome c552 and cytochrome c oxidase, (C)
S. cerevisiae cytochrome c and cytochrome bc1, (D) S. cerevisiae cytochrome c and cytochrome c peroxidase adducts. In the four panels, cytochrome c
is represented with an orientation where the ‘‘loop face’’ points towards the observer.
doi:10.1371/journal.pone.0018329.g003
Bcl-xL - Cytochrome C Complex
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on the side of cytochrome c the interaction is centred on the heme
crevice defined by the two loops, where atoms of the porphyrin
ring become partially exposed. The differences in the various
complexes might account for the structural features of the two
examined cytochromes (for example cytochrome c552 has a
different conformation of the distal loop due to the different
length of this structural element: 13 amino acids vs. 17 amino acids
in the yeast protein) as well as differences in the nature of residues
on the surface the partner proteins. Slightly different slides of the
various redox enzymes on cytochrome c surface to optimize
intermolecular contacts finely tune the interaction and results in a
different involvement of peripheral residues.
Cytochrome c in the anti-apoptotic complex shares only a few
contact residues with the electron transfer adducts. Here, the core
interactions are centred on the left side (according to the view of
Fig. 3) of the heme crevice. The loops are always involved,
reflecting the need of conformational adaptability to facilitate an
induced fit. At the same time, as the anti-apoptotic interaction
with Bcl-xL does not require any electron transfer, doesn’t need
the involvement of the solvent exposed heme edge.
Further considerations about the recognition process
Our structural model clearly emerges from the NMR data and
is consistent with pro-apoptotic mutations reported for both
cytochrome c and Bcl-xL. One could question about the relevance
of such a weak complex for blocking the apoptosome formation.
Nevertheless, two key aspects should be considered. The relatively
high ionic strength of the solution needed for in vitro experiments
(as previously discussed) is such that affinity measurements are
done far from the optimal conditions for the interaction, and the
resulting Kd values are higher than they should be. Another
difference between the in vitro experiment and the environment
inside the cell is the reduced accessible surface area for a
membrane tail-anchored protein. In considering this aspect, one
should take into account the fact that, in our in vitro NMR
experiments, both cytochrome c and Bcl-xL can freely diffuse in
three dimensions. The in vivo anti-apoptotic process of sequestra-
tion of cytochrome c by Bcl-xL can be seen as a bait and prey
process, where Bcl-xL acts as bait when anchored to the external
mitochondrial membrane and therefore has restricted motions and
increased local concentration. The prey, cytochrome c, is ‘‘fished’’
for by Bcl-xL once released in the cytosol, where in principle it may
be a three dimensional diffusant, but the proximity of the
mitochondrial membrane may still influence its diffusion modes.
Reducing the dimensionality of the recognition process between
the two proteins may lead to a sensible increase in binding
efficiency.
Prospects
Apoptosis normally eliminates cells with damaged DNA or
aberrant cell cycle. Pro-survival proteins are therefore potentially
oncogenic. Clarifying how the Bcl-2 family governs apoptosis
might provide the ability to control the apoptotic threshold.
Conventional cytotoxic therapy indirectly induces apoptosis,
but more effective outcomes could be achieved by direct
activation of the apoptotic machinery. Promising approaches
include impairing expression of pro-survival proteins or identi-
fying drugs that inhibits their action. The identification of
interfaces between partner molecules provides targets for
pharmacological intervention; the protein-protein interaction
surface between Bcl-xL and cytochrome c here identified may
offer one of these targets.
Materials and Methods
Protein samples
Full length human cytochrome c was expressed and purified as
reported in the literature [36] in the unlabeled and
15N-labeled
form.
The Bcl-xL construct used in our experiments contains residues
1–209andlacksthe C-terminalhydrophobictail.Theconstructalso
has four additional N-term residues (numbers 23 to 0). Unlabeled,
15N-labeled and
13C,
15N labeled forms of the protein were used for
different NMR experiments. The protein was expressed and
purified by ProtEra through a custom protein production service.
Typical protein concentrations for NMR experiments were in
the 50 mM to 5 mM range, in 50 mM sodium phosphate buffer at
pH 7.3, 150 mM NaCl, 1mM DTT and with 10% D2O for lock.
NMR spectroscopy
All NMR spectra were acquired at 300 K using Bruker
Advance spectrometers operating at proton frequencies of 500,
700, 800 and 900 MHz, all equipped with cryoprobes. A table
summarizing the NMR experiments performed is given in the
Supplemental Material (Table S2). NMR spectra were processed
with Topspin version 2.0 and analyzed with the program Cara
[37].
Interaction studies. Titrations of
15N human cytochrome c
with unlabeled Bcl-xL and titrations of
15N-Bcl-xL with unlabeled
cytochrome c were followed through
1H-
15N HSQC. Looking at
the
15N-enriched Bcl-xL the system was studied until a ratio of Bcl-
xL: cytochrome c 1:10. Looking at the
15N-enriched cytochrome c
we could reach a cytochrome c : Bcl-xL ratio of 1:20.
Assignment of Bcl-xL. Backbone resonance assignments of
Bcl-xL were performed through conventional multidimensional
NMR techniques based on triple resonance experiments, as
summarized in Table S2. The assignment was carried out starting
from the reported assignment (BMRB entry 6578) [38], that refers
to a dimeric form of the protein lacking the 45–84 flexible loop.
We have accomplished 84% and 80% assignment of the Ca and
HN backbone resonances, respectively.
R2 measurements. The generalized increase in
15NR 2
relaxation rates of Bcl-xL was used to monitor the increase in
average molecular size in the presence of 2-fold and 4-fold excess
of cytochrome c. The experimental details are provided in Table
S2. The local overheating typical of R2 measurements affects the
stability of Bcl-xL, as revealed by
1H-
15N HSQC experiments
recorded in an interleaved manner during R2 experiments. The
effect becomes more important in the presence of cytochrome c
and is proportional to its concentration. Nevertheless an overall
increase in R2, consistent with an increase in the correlation time
for tumbling was observed.
Chemical shift mapping
The interaction between cytochrome c and Bcl-xL was
monitored through chemical shift changes of the signals from
the backbone amide moieties, whose magnitude increased upon
increasing concentration of the titrant (Fig. S1 and Fig. S2). The
extent of the changes was quantified through the following
equation (Garrett value) [39]:
Dd NH ðÞ ~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Dd 1H ðÞ ½ 
2z Dd 15N ðÞ =5 ½ 
2
2
s
Kd values were obtained by plotting the weighted average
chemical shift variations of perturbed residues on the
15N-enriched
Bcl-xL - Cytochrome C Complex
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cytochrome c (Fig. S3) and were found to be in the 1–3 mM range.
Model structure calculations
A structural model of the cytochrome c2Bcl-xL adduct was
obtained using HADDOCK program [19]. HADDOCK calcu-
lations were started with the coordinates of human cytochrome c
(PDB id: 1J3S) and human Bcl-xL (PDB id: 1LXL). The starting
structure for cytochrome c is actually the first member of an
ensemble of 20 NMR conformers.
The docking process in HADDOCK is driven by ambiguous
interaction restraints (AIRs), which are derived from the available
experimental information on the residues involved in the
intermolecular interaction. A distinction is made between active
and passive residues: the former are residues which are involved in
the interaction and have a high solvent accessibility (i.e. .50%) in
the free-form protein, while the latter correspond to solvent-
accessible surface neighbors of the active residues.
The active residues defined for the present calculation are listed
in Table S3. The solvent accessibility was calculated with the
program NACCESS. The HADDOCK docking protocol consist-
ed in three steps: randomization of orientations and rigid body
minimization, semi-flexible simulated annealing in torsion angle
space and flexible solvent refinement where the structures
obtained after the semi-flexible simulated annealing are refined
in an explicit solvent layer.
Finally, the solutions were clustered following the two standard
criteria of the HADDOCK program i.e., a group of structures
forms a cluster if constituted by at least four members having a
ligand interface RMSD within 7.5 A ˚. In our case, these criteria led
to the identification of four clusters, that were ranked according to
their HADDOCK score (defined as the weighted sum of van der
Waals, electrostatic, desolvation and restrains violation energy
terms). These four clusters contain 128, 21, 6, and 11 structures,
respectively. The structural statistics calculated over all structures
of each cluster are shown in Table S1. Cluster 1 is by far the best
in terms of RMSD and energy values. The RMSD value reported
in the 6
th column of Table S1 is the average RMSD from the
cluster to the lowest overall energy model, i.e. the lowest energy
structure of cluster 1. Cluster 1, with an overall RMSD value of
0.8 A ˚, unequivocally defines the docking face for both proteins
and their relative orientations. Cluster 2 differs from cluster 1 in
the relative orientation of the two proteins, although the overall
contact surface area is the same.
Supporting Information
Figure S1 Plot of the chemical shift variation (Garrett values) of
the backbone cytochrome c amide signals in the cytochrome
c2Bcl-xL adduct. The horizontal line indicates the selected
chemical shift perturbation threshold.
(TIF)
Figure S2 Plot of the chemical shift variation (Garrett values) of
the backbone Bcl-xL amide signals in the cytochrome c2Bcl-xL
adduct. The horizontal line indicates the selected chemical shift
perturbation threshold.
(TIF)
Figure S3 Fitting of the weighted average chemical shift
variations of three perturbed residues (Leu90, Gly94, Gly200) of
the
15N-enriched Bcl-xL as a function of the concentration of the
unlabeled cytochrome c.
(TIF)
Table S1 Structural statistics calculated over all structures for
the 4 clusters obtained by HADDOCK calculations.
(PDF)
Table S2 Acquisition parameters for the NMR experiments; all
spectra were acquired at 300 K.
(PDF)
Table S3 HADDOCK active residues for Bcl-xL and cyto-
chrome c.
(PDF)
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